Vicarious Surgical (RBOT) Total Non-Current Liabilities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Total Non-Current Liabilities came in at $14.7 million in Q3 2025, down 31.56% year-on-year from $21.5 million in Q3 2024, and down 13.43% on a QoQ basis from $17.0 million in Q2 2025.
Vicarious Surgical (RBOT) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Total Non-Current Liabilities data on file, last reported at $14.7 million in Q3 2025.
- On a quarterly basis, Total Non-Current Liabilities fell 31.56% year-over-year to $14.7 million in Q3 2025; TTM through Sep 2025 was $14.7 million, a 31.56% decrease from a year earlier, with the FY2024 full-year figure at $20.2 million, down 3.94% from the prior year.
- Total Non-Current Liabilities for Q3 2025 stood at $14.7 million, down from $17.0 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for RBOT reached as high as $27.0 million in Q3 2022 and fell as low as $5.4 million in Q3 2021.
- Historically, Total Non-Current Liabilities has averaged $18.7 million across 5 years, with a median of $20.4 million in 2024.
- Across the five-year window, Total Non-Current Liabilities jumped 396.12% in 2022 and tumbled 31.56% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $8.6 million in 2021, then jumped by 171.1% to $23.2 million in 2022, then retreated by 9.3% to $21.1 million in 2023, then fell by 3.94% to $20.2 million in 2024, then retreated by 27.32% to $14.7 million in 2025.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $14.7 million in Q3 2025, $17.0 million in Q2 2025, and $20.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14.71 Mn |
| Jun 30, 2025 | 16.99 Mn |
| Mar 31, 2025 | 20.10 Mn |
| Dec 31, 2024 | 20.23 Mn |
| Sep 30, 2024 | 21.49 Mn |
| Jun 30, 2024 | 20.38 Mn |
| Mar 31, 2024 | 18.58 Mn |
| Dec 31, 2023 | 21.07 Mn |
| Sep 30, 2023 | 21.86 Mn |
| Jun 30, 2023 | 21.82 Mn |
| Mar 31, 2023 | 21.26 Mn |
| Dec 31, 2022 | 23.23 Mn |
| Sep 30, 2022 | 26.99 Mn |
| Jun 30, 2022 | 22.58 Mn |
| Mar 31, 2022 | 22.45 Mn |
| Dec 31, 2021 | 8.57 Mn |
| Sep 30, 2021 | 5.44 Mn |
| Jun 30, 2021 | 14.24 Mn |
| Mar 31, 2021 | 13.59 Mn |
| Dec 31, 2020 | -28.48 Mn |